CAS 204318-14-9

2,2',2''-[10-(2-{[(2R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutil)-4-{[(2R,3R)-1,3-diidrossibutan-2-il]carbamoil}-16-(4-idrossibenzil)-7-[(1R)-1-idrossietil]-13-(1H-indol-3-ilmetil)-6,9,12,15,18-pentaoxo-1,2-ditia-5,8,11,14,17-pentaazacicloicosan-19-

Descrizione:

La sostanza chimica con il nome "2,2',2''-[10-(2-{[(2R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutil)-4-{[(2R,3R)-1,3-diidrossibutan-2-il]carbamoil}-16-(4-idrossibenzil)-7-[(1R)-1-idrossietil]-13-(1H-indol-3-ilmetil)-6,9,12,15,18-pentaoxo-1,2-ditia-5,8,11,14,17-pentaazacicloicosan-19-" e numero CAS "204318-14-9" è una molecola organica complessa caratterizzata dalla sua struttura intricata, che include più gruppi funzionali e stereocentri. Questo composto probabilmente presenta un'attività biologica significativa a causa delle sue caratteristiche strutturali, che possono includere gruppi amminici, idrossilici e carbonilici, contribuendo alle sue potenziali interazioni con bersagli biologici. La presenza di un nucleo di pentaazacicloicosano suggerisce un quadro ciclico unico che può influenzare la sua farmacocinetica e farmacodinamica. Inoltre, la stereochimica indicata dalle designazioni (R) e (S) implica che la molecola può avere disposizioni spaziali specifiche che sono cruciali per la sua funzione biologica. In generale, questa sostanza rappresenta un esempio sofisticato di chimica organica sintetica con potenziali applicazioni in chimica medicinale o nello sviluppo di farmaci.

Formula: C₆₅H₉₂N₁₄O₁₈S₂

InChI: InChI=1/C65H92N14O18S2/c1-39(81)51(36-80)72-64(96)53-38-99-98-37-52(73-60(92)48(28-41-10-4-3-5-11-41)68-54(84)32-76-20-22-77(33-55(85)86)24-26-79(35-57(89)90)27-25-78(23-21-76)34-56(87)88)63(95)70-49(29-42-15-17-44(83)18-16-42)61(93)71-50(30-43-31-67-46-13-7-6-12-45(43)46)62(94)69-47(14-8-9-19-66)59(91)75-58(40(2)82)65(97)74-53/h3-7,10-13,15-18,31,39-40,47-53,58,67,80-83H,8-9,14,19-30,32-38,66H2,1-2H3,(H,68,84)(H,69,94)(H,70,95)(H,71,93)(H,72,96)(H,73,92)(H,74,97)(H,75,91)(H,85,86)(H,87,88)(H,89,90)/t39-,40-,47+,48-,49+,50-,51-,52+,53+,58+/m1/s1

DOTA-(Tyr³)-Octreotide

CAS: 204318-14-9

Somatostatin analog for tumor scintigraphy and radionuclide therapy.

Formula: C₆₅H₉₂N₁₄O₁₈S₂

Purezza: 98.4%

Colore e forma: White

Peso molecolare: 1421.66

Ref: 01-4043535

2,2',2''-(10-(2-(((R)-1-(((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-10-(4-aminobutyl)-4-(((2R,3R)-1,3-dihydroxybutan-2-yl)carbamoyl)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid

CAS: 204318-14-9

Formula: C₆₅H₉₂N₁₄O₁₈S₂

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 1421.6390

Ref: IN-DA0029FD

Edotreotide

CAS: 204318-14-9

Edotreotide

Purezza: ≥95%

Peso molecolare: 1421.64g/mol

Ref: 54-BUP02634

Edotreotide

CAS: 204318-14-9

Edotreotide (SMT-487) is an Indicator and Reagent. It also is used in the Diagnosis and Staging of Tumors Expressing Somatostatin Receptors.

Formula: C₆₅H₉₂N₁₄O₁₈S₂

Purezza: 96.95%

Colore e forma: Solid

Peso molecolare: 1421.64

Ref: TM-T20204

Edotreotide trifluoroacetate

CAS: 204318-14-9

Edotreotide trifluoroacetate is a diagnostic agent that is used to diagnose hepatic steatosis. It is a synthetic analog of somatostatin, which can be synthesized by the reaction of trifluoroacetic acid and hydroxyl compounds. Edotreotide trifluoroacetate is radiolabeled with technetium-99m and administered intravenously. The drug binds to receptors on the surface of proximal tubule cells in the liver, causing an uptake of this radionuclide in the area of interest. This diagnostic agent has also been shown to inhibit insulin release from pancreatic beta cells and improve glucose tolerance in patients with type 2 diabetes mellitus.

Formula: C₆₅H₉₂N₁₄O₁₈S₂·xC₂HF₃O₂

Purezza: Min. 95%

Colore e forma: Powder

Ref: 3D-FE175690